News and Articles

New Lawsuit Filed Blaming DVT on NuvaRing: AttorneyOne.com Provides Advice and Solutions for the Alleged Side Effects from NuvaRing

According to court documents, in a suit filed on Jan. 9 in the Eastern District of Texas, Sherman Division, no. 4:12-cv-00008, a Danton woman, Dawn Kregel, used the NuvaRing for just over a month in 2010. NuvaRing is a contraceptive in vaginal ring form. Kregel accuses the company manufacturing NuvaRing in a $10 million lawsuit stating she was diagnosed with a DVT, allegedly caused by the defendants\' products. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with so anyone can easily and inexpensively deal with cases of NuvaRing side effects.

Read more

House Democrats Call for Safety Hearings on Lap Bands and Transvaginal Mesh

Ennis & Ennis, P.A. Supports the House Democrat’s Position in Questioning Whether FDA Medical Device Approval Process Protects the Public

Read more

New Lubricant Designed to Help Couples Get Pregnant

For many couples, rather than being an enjoyable experience, trying to get pregnant can actually become a stressful and even a depressing experience. This is especially true when conception does not occur within the first year of trying. A new product, called Zestica Fertility, recently approved by Health Canada, is now available to help couples increase their chances of conceiving.

Read more

Innovative Product Improves Chances of Conception

It may be surprising to know that 10% of Canadian couples have a difficult time conceiving. By age 30, experts say, a woman\'s chance of conceiving each month is about 20%, and by the time she reaches the age of 40, it drops to 5%. A new product, called Zestica Fertility, recently approved by Health Canada, is now available to help couples increase their chances of conceiving.

Read more

Rise in Elective C-Sections May Increase Risk of Surgical Adhesions in Moms

With the number of women having cesarean sections on the rise, the risk of post-operative abdominal scar tissue, or adhesions, among mothers may also be increasing. Adhesion Related Disorder activist Karen Steward today joined the call for obstetricians to consider the risk of adhesion-related complications when recommending cesarean versus vaginal delivery.

Read more

Rise in Elective C-Sections May Increase Risk of Surgical Adhesions in Moms

With the number of women having cesarean sections on the rise, the risk of post-operative abdominal scar tissue, or adhesions, among mothers may also be increasing. Adhesion Related Disorder activist Karen Steward today joined the call for obstetricians to consider the risk of adhesion-related complications when recommending cesarean versus vaginal delivery.

Read more

EurekaMag.com Publishes New Reviews of Aurora Borealis, Bayam and Uterus Didelphys

The geographical and health sciences website EurekaMag.com publishes insights into specific subjects of all areas of geographical and health science. The latest reviews cover Aurora borealis which are the Northern Lights caused by radiation emitted as light from atoms in the upper atmosphere as they are hit by fast-moving electrons and protons, and bayam which is amaranth, a herb with approximately 60 species and inflorescences and foliage ranging from purple to red and gold. The latest insight into Uterus didelphys is about a uterine malformation where the uterus is present as a paired organ as the embryogenetic fusion of the mullerian ducts failed to occur.

Read more

FDA Orders Companies to Examine Complication Rates of Transvaginal Mesh Implants: AttorneyOne Notes Adverse Events Reports Are Increasing

Earlier this month, the FDA probed major companies on transvaginal mesh risk. Transvaginal surgical mesh is used to treat pelvic organ prolapse (POP) and Stress Urinary Incontinence (SUI). Lawsuits have been filed against C.R. Bard, the manufacturer of Bard Avaulta mesh, alleging the Bard Avaulta System is defective. The Bard Avaulta litigation was consolidated in October 2010 as part of an MDL (No.2187) in the US District Court for the Southern District of West Virginia. On January 26, the U.S. Judicial Panel on Multidistrict Litigation (JPML) will hear arguments over whether several transvaginal mesh lawsuits involving other manufacturers should also be centralized as part of three separate for coordinated handling. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal council so anyone can easily and inexpensively deal with cases of transvaginal surgical mesh complications.

Read more

FDA Requires Transvaginal Mesh Makers to Study Risks

Ennis & Ennis, P.A. explains the FDA’s Order to manufacturers of transvaginal mesh devices requiring safety studies to be conducted on the devices used to treat pelvic organ prolapse and stress urinary incontinence.

Read more

FDA Requires Transvaginal Mesh Makers to Study Risks

Ennis & Ennis, P.A. explains the FDA’s Order to manufacturers of transvaginal mesh devices requiring safety studies to be conducted on the devices used to treat pelvic organ prolapse and stress urinary incontinence.

Read more

Femanol, Vaginal Odors Worst Enemy, Celebrates Five Year Anniversary

MedcoSouth Healthcare LLC announces the five year anniversary of its ground breaking product, Femanol.

Read more

FDA Requires Transvaginal Mesh Makers To Conduct Safety Studies

Bernstein Liebhard LLP endorses an FDA mandate requiring transvaginal mesh manufacturers to initiate investigations into implant related injuries.

Read more

Rottenstein Law Group Launches Website to Inform Public About Dangers of Transvaginal Mesh

The Rottenstein Law Group, which represents clients with claims stemming from the harmful adverse effects of surgical mesh, has launched a new website designed specifically to inform the public about the devices and the unfortunate severe consequences that can result after implantation.

Read more

Rottenstein Law Group Launches Website to Inform Public About Dangers of Transvaginal Mesh

The Rottenstein Law Group, which represents clients with claims stemming from the harmful adverse effects of surgical mesh, has launched a new website designed specifically to inform the public about the devices and the unfortunate severe consequences that can result after implantation.

Read more

Senate Introduces Bill To Track Implant Failure Rates

Bernstein Liebhard LLP endorses a new bill that would force medical device manufacturers to track the performance of implants, including artificial hips and vaginal mesh.

Read more

Bernstein Liebhard LLP Announces Revamped Consumer Information Website

The law firm of Bernstein Liebhard LLP announces the launch of its newly revamped website, ConsumerInjuryLawyers.com, which provides a wealth of consumer information concerning dangerous drugs, defective medical devices and consumer products.

Read more

Parker McDonald Reports on Recent Recommendations for the Use of Vaginal Mesh

Parker McDonald Law reports that the Joint Committee recommended that the use of synthetic transvaginal mesh only be used for \"high-risk women whom the benefit may justify the risk.\"

Read more

Mesh Resource Center Launched as TransVaginal Mesh Lawsuits Combined, Set for Trials in New Jersey

Transvaginal-meshlawsuit.com launches with the largest resource site on the web for those affected by vaginal mesh complications.

Read more

Dr. Miklos and Dr. Moore of Atlanta Center for Aesthetic Vaginal Surgery Published the 1st Paper on Performing a Simultaneous Labia Minora and Majora Reduction Surgery

Drs. Miklos & Moore continue their pursuit of surgical excellence and extraordinary results in cosmetic vaginal surgery.

Read more

Transvaginal Surgical Mesh Side Effect Complaints Being Investigated By Gilman Law LLP

Gilman Law LLP, a leading national law firm with over 30 years of experience protecting the rights of victims is actively investigating complaints involving complications with the use of transvaginal surgical mesh and bladder slings to treat pelvic organ prelapse (POP) and stress urinary incontinence (SUI).

Read more